In addition, the receiver operating characteristic curve also showed an area under the curve value close to 1, with a p‐value less than 0.05, which suggests that the glucagon level may be used as an accurate model to predict chemotherapy response in patients with CRC. This evidence concerns the gene GCG and colorectal carcinoma.